← Back to Search

Outpatient for Osteoarthritis

N/A
Waitlist Available
Led By Brent Lanting, MD, FRCSC
Research Sponsored by Lawson Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This trial is comparing the standard inpatient treatment for hip arthroplasty with a same day discharge option for patients who meet certain criteria. The goal is to compare the costs and benefits from various perspectives.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Early complications and adverse events
Indirect and Direct Costs of Treatment
Standardized measure of health outcome (EQ-5D)
Secondary outcome measures
Caregiver Assistance Scale
Caregiver Strain Index
Harris Hip Score
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: OutpatientExperimental Treatment1 Intervention
Patients in the outpatient group (same day discharge following THA) are discharged the same day following surgery. All patients are required to meet the discharge criteria to be sent home (i.e., capable of using crutches, relatively free of pain, free of nausea and vomiting, free of excess bleeding, alert and oriented, given take-home medications, and in the company of a caregiver).
Group II: InpatientActive Control1 Intervention
Patients in the inpatient group (following day discharge following THA) stay in the hospital overnight and then are discharged home the next day. All patients are required to meet the discharge criteria to be sent home (i.e., capable of using crutches, relatively free of pain, free of nausea and vomiting, free of excess bleeding, alert and oriented, given take-home medications, and in the company of a caregiver).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Outpatient
2015
N/A
~1060

Find a Location

Who is running the clinical trial?

Lawson Health Research InstituteLead Sponsor
659 Previous Clinical Trials
413,174 Total Patients Enrolled
21 Trials studying Osteoarthritis
5,009 Patients Enrolled for Osteoarthritis
University of Western Ontario, CanadaOTHER
164 Previous Clinical Trials
318,688 Total Patients Enrolled
8 Trials studying Osteoarthritis
949 Patients Enrolled for Osteoarthritis
Brent Lanting, MD, FRCSCPrincipal InvestigatorLondon Health Sciences Centre
1 Previous Clinical Trials
300 Total Patients Enrolled

Frequently Asked Questions

~56 spots leftby Apr 2025